(19)
(11) EP 1 259 493 A2

(12)

(88) Date of publication A3:
07.02.2002

(43) Date of publication:
27.11.2002 Bulletin 2002/48

(21) Application number: 01911085.7

(22) Date of filing: 22.02.2001
(51) International Patent Classification (IPC)7: C07D 241/04, C07D 241/08, C07D 241/42, C07D 295/108, C07D 317/54, C07D 317/58, A61K 31/495, A61K 31/498, A61K 31/4995, A61P 9/00
(86) International application number:
PCT/US0105/606
(87) International publication number:
WO 0106/2744 (30.08.2001 Gazette 2001/35)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 22.02.2000 US 184182 P
22.02.2000 US 184457 P
22.02.2000 US 184306 P
23.05.2000 US 206396 P
05.06.2000 US 209262 P

(71) Applicant: CV THERAPEUTICS, INC.
Palo Alto, CA 94304 (US)

(72) Inventors:
  • ZABLOCKI, Jeff
    Mountain View, CA 94040 (US)
  • ELZEIN, Elfatih
    Fremont, CA 94555 (US)
  • NUDELMAN, Grigory
    Pacifica, CA 94044 (US)
  • MARQUART, Tim
    San Francisco, CA 94112 (US)
  • VARKHEDKAR, Vaibhav
    Sunnyvale, CA 94086 (US)
  • IBRAHIM, Prabha, N.
    Mountain View, CA 94040 (US)
  • PALLE, Venkata, P.
    Mountain View, CA 94041 (US)
  • BLACKBURN, Brent, K.
    Los Altos, CA 94022 (US)

(74) Representative: Vossius, Volker, Dr. et al
Dr. Volker Vossius,Patentanwaltskanzlei - Rechtsanwaltskanzlei,Geibelstrasse 6
81679 München
81679 München (DE)

   


(54) SUBSTITUTED PIPERAZINE COMPOUNDS